title: Serotonin and 5-hydroxyindole-acetic acid.
abstract: BACKGROUND
  In patients suffering from chronic renal insufficiency (CRI) serotonin (5HT) metabolism is impaired, and plasma 5-hydroxyindoleacetic acid (5HIAA) levels (main metabolite of 5HT) are increased.
  
  
  OBJECTIVE
  In this study we aimed to give a detailed description of peripheral serotonin metabolism in healthy subjects and patients with CRI, and to evaluate the efficacy of hemodialysis in the elimination of cumulated 5HT and 5HIAA.
  
  
  METHODS
  5HT (platelet rich plasma, platelet poor plasma, urine, HPLC with electrochemical detection) and 5HIAA (plasma, urine, HPCL with electrochemical detection) levels were evaluated in 14 conservatively treated (CT) and 12 hemodialysed (HD) patients with CRI and were compared to those of 60 healthy volunteers (HV).
  
  
  RESULTS
  In patients with CRI accumulation of 5HT and 5HIAA in plasma with no changes in platelet 5HT content was revealed. 5HT renal and fractional excretion (FE) was markedly decreased in CRI. FE-5HT was < 1 in all investigated subjects, indicating its reabsorption in proximal tubules, or local degradation to 5HIAA. Due to the increased filtration load renal excretion of 5HIAA was not altered in CT patients, however it was decreased in HD patients. The relative participation of glomerular filtration in 5HIAA renal excretion increased in CRI. FE-5HIAA > 5 was found in 20% of HV and 15% of CT, pointing indirectly to 5HIAA intrarenal production. In CRI FE-5HIAA decreased. HD did not eliminate accumulated 5HT and 5HIAA effectively.
  
  
  CONCLUSIONS
  Increased levels of 5HT and 5HIAA might exert metabolic effects contributing to the clinically manifested impairments characteristic for uremic syndrome. (Tab. 3, Fig. 3, Ref. 27.)
authors.affiliation: Institute of Preventive and Clinical Medicine, Bratislava, Slovakia. sebekova@upkm.sk
authors.forename: K
authors.initials: K
authors.lastname: Sebekova
authors.forename: V
authors.initials: V
authors.lastname: Spustova
authors.forename: K
authors.initials: K
authors.lastname: Opatrny
authors.forename: R
authors.initials: R
authors.lastname: Dzurik
mesh_terms: D000328:Adult; D000368:Aged; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D006435:Renal Dialysis; D012701:Serotonin / Q000097:blood*
chemical_list: D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D003404:Creatinine